Purchases and Sales Made in Q1 2024 in Kymera Therapeutics, Inc. (KYMR)
This table provides information about the institutional ownership of Kymera Therapeutics, Inc. (KYMR) during Q1 2024. The information is specifically focused on institutions that hold shares of Kymera Therapeutics, Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
May 15, 2024
Q1 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-155K- 79.07% |
$3.55M - $6.75M
|
41K
$1.85M
|
|
|
May 10, 2024
Q1 2024
|
Dimensional Fund Advisors LP
Austin, TX |
SELL
|
- |
-185K- 34.57% |
$4.23M - $8.04M
|
349K
$15.8M
|
|
|
May 15, 2024
Q1 2024
|
Deer Management Co. LLC
Larchmont, NY |
SELL
|
- |
-200K- 32.47% |
$4.58M - $8.71M
|
416K
$18.8M
|
|
|
May 15, 2024
Q1 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-224K- 33.22% |
$5.13M - $9.77M
|
451K
$20.4M
|
|
|
May 03, 2024
Q1 2024
|
Atlas Venture Life Science Advisors, LLC
|
SELL
|
- |
-481K- 8.21% |
$11M - $21M
|
5.38M
$243M
|
|
|
May 15, 2024
Q1 2024
|
Aquilo Capital Management, LLC
San Francisco, CA |
SELL
|
- |
-493K- 55.89% |
$11.3M - $21.5M
|
389K
$17.6M
|